AT THE AHS ANNUAL MEETING

WASHINGTON (FRONTLINE MEDICAL NEWS)Individuals suffering from migraine who also regularly experience insomnia are highly predisposed to developing anxiety and depression, according to a population-based study presented at the annual meeting of the American Headache Society .

“Treating comorbid conditions, such as anxiety and depression, is an essential part of optimal treatment of migraine,” explained Dr. Min Chu of Hallym University in Anyang, South Korea. “However, anxiety and depression, even in migraineurs, are usually underdiagnosed and undertreated, [and] the association between insomnia and anxiety and depression among migraineurs in a population-based setting is still unknown.”

Dr. Chu and his coinvestigators selected a sample of 2,762 participants aged 19-69 years who underwent screening with the Insomnia Severity Index (ISI) , Goldberg Anxiety Scale , and Patient Health Questionnaire–9 to determine each patient’s severity for each symptom. ISI scores equal to or greater than 15 were considered indicative of insomnia severe enough to potentially cause anxiety or depression. Evaluations for each subject were administered via a face-to-face, 60-item, semistructured interview.

Of 147 subjects found to have migraine in the previous year, 57 (38.8%) had insomnia, 45 (30.6%) had anxiety, and 26 (17.7%) had depression. Of the 57 migraineurs who also had insomnia, 50.9% had anxiety and 31.6% had depression. Logistic regression models ultimately showed that migraine and insomnia together create heightened odds for anxiety (odds ratio, 4.8; 95% confidence interval, 2.3-10.1) and depression (OR, 4.7; 95% CI, 1.9-11.8) (P < .001 for all). Out of the total population, 274 subjects (10.0%) had anxiety, 124 (4.5%) had depression, and 120 (4.3%) had insomnia.

“Insomnia, anxiety, and depression showed a close association in a population-based sample,” Dr. Chu said. “This association persisted among migraineurs, and more than two-thirds of migraineurs with insomnia have anxiety or depression.”

He added that it is critical for health care providers to assess insomnia in migraineurs to accurately treat anxiety and depression as well.

Dr. Chu did not report any relevant financial disclosures.

dchitnis@frontlinemedcom.com

Ads

You May Also Like

Exploratory analysis provides support for Recurrence Score

AT EBCC10 AMSTERDAM (FRONTLINE MEDICAL NEWS) – A 21-gene expression assessment tool may identify ...

Nitric oxide nanoparticles prevent acne inflammation

FROM JOURNAL OF INVESTIGATIVE DERMATOLOGY Nitric oxide–releasing nanoparticles prevent Propionibacterium acnes–induced inflammation by clearing ...

Study: PDT with methyl aminolevulinate promising for severe acne

FROM THE BRITISH JOURNAL OF DERMATOLOGY Methyl aminolevulinate plus photodynamic therapy shows promise as ...